GHK-Cu for hair loss: what the peptide data actually shows

What did @canadamanda36 actually say?

She said she started GHK-Cu alongside her GLP-1 (semaglutide, branded as Rybelsus or likely referring to a compounded tirzepatide product) because she was worried about hair loss, and she credits the peptide with reversing her thinning and thickening her hair. Her recommendation is direct: "add the GHK-Cu to it, it makes a difference." She also mentions a skin benefit.

To be clear about what this is: a personal anecdote from a single user over an unspecified time period, with no baseline photos, no control condition, and no way to separate the peptide's effect from postpartum hair cycling, dietary changes, or weight-loss-related nutritional shifts. That doesn't mean she's wrong. It means we can't know from this video alone.

Does the science back this up?

There is legitimate early-stage research on GHK-Cu and hair follicles, but calling it proven would be a stretch. The evidence is real but thin, largely preclinical, and far from the controlled human trials we'd want before confidently recommending a stack.

GHK-Cu (copper tripeptide-1) has been studied for effects on dermal papilla cells, which are the cells that drive hair follicle cycling. A study by Pickart and Margolina (2018, Biomolecules) reviewed GHK-Cu's broad regenerative signaling properties, including effects on skin remodeling. Separate cell-culture work has shown GHK-Cu can stimulate follicle elongation and upregulate growth factors like VEGF and KGF, which matter in hair cycling. A study by Kang et al. (2014, Archives of Dermatological Research) found topical copper peptide formulations had measurable effects on hair follicle size in rodent models. These are real signals, not invented ones. But rodent follicle studies and human clinical outcomes are different things.

On the GLP-1 side, telogen effluvium (temporary diffuse shedding) is a recognized side effect of rapid weight loss, not specifically from GLP-1 receptor agonists themselves. The mechanism is metabolic stress, not the drug's direct action on follicles.

What did they get wrong (or right)?

She got the biological plausibility right. GHK-Cu does have a real research basis for hair and skin effects. The postulation that it might offset stress-related shedding during weight loss is not crazy. That's fair to acknowledge.

What she got wrong, or at least oversimplified, is the causal attribution. Her hair improving while taking GHK-Cu does not mean GHK-Cu caused it. Postpartum hair loss typically resolves on its own within 6 to 12 months after delivery. If she's in that window, her hair was likely going to recover regardless. Additionally, GLP-1 associated shedding, if it occurs, typically begins 3 to 6 months into treatment. She may simply not be in the window yet.

Her blanket recommendation, "add the GHK-Cu to it," oversimplifies the picture. The peptide is not regulated by the FDA for hair loss. Dosing, delivery method (topical vs. injectable), and individual response vary considerably. Telling 3,000 viewers to just add a peptide to their GLP-1 regimen, without mentioning medical supervision, is where this video goes off track.

What should you actually know?

GHK-Cu is one of the more credible peptides in the cosmetic and regenerative research space. It is not a fringe compound. But "credible research exists" and "this will grow your hair back" are separated by a large gap that personal testimonials cannot close.

If you're on a GLP-1 and concerned about hair loss, the actual evidence-based starting points are protein adequacy (hair loss during weight loss is often tied to insufficient protein intake, per studies like Aoi et al., 2012, PLOS ONE), iron and ferritin levels, and thyroid function. These are free to check and frequently the actual culprit.

GHK-Cu used under medical supervision, particularly topical applications with established safety profiles, is a reasonable conversation to have with a provider. Stacking unregulated injectable peptides without clinical oversight is not something any responsible platform should recommend without a proper assessment.

• GLP-1 related hair shedding is real but likely temporary and tied to caloric deficit, not the drug itself.
• GHK-Cu has biological mechanisms that are plausible for hair support, but human RCT data is limited.
• Postpartum hair cycling alone could explain her results.
• No one should add peptides to a prescription medication regimen without speaking to a clinician first.